Back to the main directory
EarningsReview / Equity
- UK staffing data for February: Challenging but rate of decline eases by BNP Paribas Exane
- Germany ‘steps up’ - how Siemens benefits by BNP Paribas Exane
- HusCompagniet - Danish homebuilding customers still holding back by Danske Bank Equity Research
- Merck - CONFIDENT ABOUT LIFE SCIENCE by Equita Sim
- NY Fieldtrip 2025 feedback by BNP Paribas Exane
- NY Fieldtrip 2025 feedback by BNP Paribas Exane
- FY24 results: Portfolio value stable in H2 with ’25 AFFO guide 1% ahead by BNP Paribas Exane
- NY Fieldtrip 2025 by BNP Paribas Exane
- Q4'24 results: Stellar Q4; EU orders rebounding; FY25 guide conservative? by BNP Paribas Exane
- INVEST SECURITIES - BIOMERIEUX : Champion de la croissance, un plan GO-28 en marche - ACHAT, OC 133€ vs 130€ by Invest Securities
- MINING NOTE, STRATEGY, US IMPORT, ACX, OUT1V, STAINLESS, US TARIFFS, CHINA INFLATION, COPPER by BNP Paribas Exane
- Prada - SOLID INVESTMENT CASE SLIGHTLY BLURRED BY RUMORS ON VERSACE by Equita Sim
- Canola business: cold-pressed between China and US tariffs by BNP Paribas Exane
- Q4'24 conf. call feedback by BNP Paribas Exane
- REDEFINE-2 somewhat disappointing in our view by BNP Paribas Exane
- How much of the humanoid-robot opportunity is priced in? by BNP Paribas Exane
- Crouching Tiger Hidden Wafer: China’s EUV Leap? Not quite. by BNP Paribas Exane
- Diverging fortunes by BNP Paribas Exane
- Manx Financial Group - Termination of coverage by Edison Investment Research
- Q4 EBITDA beat, FY25 guided ahead by BNP Paribas Exane
- A slow start to 2025 by BNP Paribas Exane
- BNPP TMT Conference feedback: SAP by BNP Paribas Exane
- TMT Conference London Day 1 - Feedback by BNP Paribas Exane
- Norva24 (Hold, TP: SEK36.50) - SEK36.50/share cash offer by DnB Markets
- Set for spicy growth by DnB Markets